SCHEMBL13610366

SCHEMBL13610366

FC(F)(F)Oc1ccc(CSSSCc2ccco2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.46
TSHR P16473 2/20 0.42
TRPC5 Q9UL62 1/20 0.41
EPHX1 P07099 2/20 0.39
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
ALDH1A1 P00352 5/20 0.37
MAPT P10636 2/20 0.37
POLB P06746 1/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
RECQL P46063 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
ADORA2A P29274 1/20 0.35
SLC6A4 P31645 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13610294 0.81 ALDH1A1 (0.50) TSHRALDH1A1MAPTPOLBALOX15
SCHEMBL13610336 0.79 MEN1 (0.53) RAB9ATSHRALDH1A1MAPTPOLB
SCHEMBL25435114 0.76 TSHR (0.47) RAB9ATSHRALDH1A1MAPTPOLB
SCHEMBL13610372 0.76 BCHE (0.43) TSHREPHX1BCHEACHEALDH1A1
SCHEMBL25435426 0.73 TSHR (0.43) RAB9ATSHRALDH1A1MAPTPOLB
SCHEMBL13610384 0.72 TSHR (0.46) TSHRTRPC5EPHX1ALDH1A1POLB
SCHEMBL13610373 0.71 MEN1 (0.45) EPHX1BCHEACHEMAPTSCN9A
SCHEMBL13610378 0.71 BCHE (0.47) TSHREPHX1BCHEACHEALDH1A1
SCHEMBL13610379 0.70 EPHX1 (0.40) RAB9AEPHX1BCHEACHEALDH1A1
SCHEMBL13610374 0.70 ALDH1A1 (0.42) RAB9ATSHREPHX1BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1742635-B1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES INC (US) 2018-03-07 EP disclosed
US-8334316-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES, INC. (US) 2012-12-18 US disclosed
US-8334316-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES, INC. (US) 2012-12-18 US disclosed
US-7622507-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES INC. (US) 2009-11-24 US disclosed
US-7622507-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES INC. (US) 2009-11-24 US disclosed
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES, INC. (US) 2009-07-30 US disclosed
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES, INC. (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF TST, CTH, CBS RAB9A 4609/4885TSHR 1867/4885TRPC5 1984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.